What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-09-29 compared with 2024-09-30 · 27 added, 25 removed, 49 unchanged (51% of the section changed)

MARKET FOR REGISTRANT'S COMMON EQUITY,

RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

MARKET FOR REGISTRANT'S COMMON

EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

(a) Market Information

7 unchanged sentences

Fourth Fiscal Quarter

The number of holders of record of our common stock

at September 1, 2024 was approximately 1,539.

The number of holders of record of our common

stock at September 1, 2025 was approximately 1,471.

Many of our shares of common stock are held by brokers and other institutions on behalf

8 unchanged sentences

and will depend on our future earnings, if any, our capital requirements and financial condition, and other relevant factors.

No preferred shares are outstanding at this time.

During fiscal year 2023 the Company paid an aggregate dividend of $0 cash, respectively, on shares of Series B Preferred Stock and Series

C Preferred Stock which were outstanding during the year.

A dividend of $1,000 was accrued on Series B Preferred Stock during the 2022

From July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value

of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter.

The Series B Preferred stock was mandatorily redeemable at $100 per share by the Company three years after issuance and accordingly was

classified as a liability.

The 200 shares have reached their maturity date and the Company approved the redemption of the Series B preferred

stock during the quarter ended December 31, 2021 and the final 200 shares of Series B redeemable convertible Preferred stock were redeemed

for $41,000, which included the $21,000 in accrued dividend payable.

(d) Securities Authorized for Issuance Under

Equity Compensation Plans

No preferred shares are outstanding as of June

30, 2025 and 2024.

A dividend of $1,000 was accrued on Series B Preferred Stock during the 2022 fiscal year.

From July 1, 2014, the Company

had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the

option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter.

The Series B Preferred stock was mandatorily

redeemable at $100 per share by the Company three years after issuance and accordingly was classified as a liability.

The 200 shares have

reached their maturity date and the Company approved the redemption of the Series B preferred stock during the quarter ended December

31, 2021 and the final 200 shares of Series B redeemable convertible Preferred stock were redeemed for $41,000, which included the $21,000

in accrued dividend payable.

(d) Securities Authorized for Issuance

Under Equity Compensation Plans

In June 2006 the Company adopted its 2006 Consolidated

11 unchanged sentences

Plan (as amended), including all options granted under prior merged plans, and were merged into the 2021 Equity Incentive Plan.

of June 30, 2024, the Company had no outstanding contingent Stock Bonuses.

In December 2021 the Company adopted its 2021 Equity

Incentive Plan, as amended ("2021 Equity Plan").

The 2021 Equity Plan was ratified by the Company's shareholders in April

June 30, 2025, the Company had no outstanding contingent Stock Bonuses.

In December 2021 the Company adopted its 2021

Equity Incentive Plan, as amended ("2021 Equity Plan").

The 2021 Equity Plan was ratified by the Company's shareholders

in April 2022.

Under the 2021 Equity Plan, Directors may grant Shares, Options, Stand Alone Stock Appreciation Rights ("SAR's"),

10 unchanged sentences

2006 Equity Compensation Plan table

Number of securities to be issued upon the

exercise of outstanding options, warrants

average exercise price of outstanding options, warrants and rights

of Securities remaining available for future issuance under equity compensation plans

Plan category

Number of securities to be issued upon the exercise of outstanding options, warrants

Weighted average exercise price of outstanding options, warrants and rights

Number of Securities remaining available for future issuance under equity compensation plans

Equity compensation plans

4 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity